Trial intelligence / Profile preview

Escalating Anti-fungal Prophylaxis in Allo-HSCT

NCT04273178Phase 2Unknown

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Jan 2020
Primary completion
Jan 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of fluconazole, voriconazole, posaconazole in invasive fungal disease (IFD), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.

02

Drugs

fluconazolevoriconazoleposaconazole
03

Conditions

invasive fungal disease (IFD)

Beyond the preview

Go deeper on NCT04273178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04273178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call